• Michele Cavallari, Svetlana Egorova, Brian C Healy, Miklos Palotai, Juan Carlos Prieto, Mariann Polgar-Turcsanyi, Shahamat Tauhid, Mark Anderson, Bonnie Glanz, Tanuja Chitnis, and Guttmann Charles R G CRG Center for Neurological Imaging, Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA..
• Center for Neurological Imaging, Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
• J Neuroimaging. 2018 May 1; 28 (3): 273-277.

Background And PurposeEnlarged perivascular spaces (EPVSs) have been associated with relapses and brain atrophy in multiple sclerosis (MS). We investigated the association of EPVS with clinical and MRI features of disease worsening in a well-characterized cohort of relapsing-remitting MS patients prospectively followed for up to 10 years.MethodsBaseline EPVSs were scored on 1.5T MRI in 30 converters to moderate-severe disability, and 30 nonconverters matched for baseline characteristics.ResultsEPVS scores were not significantly different between converters and nonconverters, nor associated with accrual of lesions or brain atrophy.ConclusionsOur preliminary findings from a relatively small study sample argue against a potential use of EPVS as early indicator of risk for disease worsening in relapsing-remitting MS patients in a clinical setting. Although the small sample size and clinical 1.5T MRI may have limited our ability to detect a significant effect, we provided estimates of the association of EPVS with clinical and MRI indicators of disease worsening in a well-characterized cohort of MS patients.Copyright © 2017 by the American Society of Neuroimaging.

27 keywords...

hide…